R01 GM042699/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1997	1
1998	1
1999	4
2000	2
2003	1
2005	1
2006	2
2007	8
2008	2
2009	5
2011	5
2012	8
2013	3
2014	5
2015	6
2016	4
2017	3
2018	4
2019	3
2020	5
2021	3
2022	5
2023	2
2024	1

1

RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.

Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RK, Hua Y, Gueroussov S, Najafabadi HS, Hughes TR, Morris Q, Barash Y, Krainer AR, Jojic N, Scherer SW, Blencowe BJ, Frey BJ. Xiong HY, et al. Science. 2015 Jan 9;347(6218):1254806. doi: 10.1126/science.1254806. Epub 2014 Dec 18. Science. 2015. PMID: 25525159 Free PMC article.

2

Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Buratti E, Chivers M, Královicová J, Romano M, Baralle M, Krainer AR, Vorechovsky I. Buratti E, et al. Nucleic Acids Res. 2007;35(13):4250-63. doi: 10.1093/nar/gkm402. Epub 2007 Jun 18. Nucleic Acids Res. 2007. PMID: 17576681 Free PMC article.

3

Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.

Bennett CF, Krainer AR, Cleveland DW. Bennett CF, et al. Annu Rev Neurosci. 2019 Jul 8;42:385-406. doi: 10.1146/annurev-neuro-070918-050501. Annu Rev Neurosci. 2019. PMID: 31283897 Free PMC article. Review.

4

RNA therapeutics.

Hastings ML, Krainer AR. Hastings ML, et al. RNA. 2023 Apr;29(4):393-395. doi: 10.1261/rna.079626.123. RNA. 2023. PMID: 36928165 Free PMC article.

5

Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy.

Marasco LE, Dujardin G, Sousa-Luís R, Liu YH, Stigliano JN, Nomakuchi T, Proudfoot NJ, Krainer AR, Kornblihtt AR. Marasco LE, et al. Cell. 2022 Jun 9;185(12):2057-2070.e15. doi: 10.1016/j.cell.2022.04.031. Cell. 2022. PMID: 35688133 Free PMC article.

6

Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.

Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR. Hua Y, et al. Nature. 2011 Oct 5;478(7367):123-6. doi: 10.1038/nature10485. Nature. 2011. PMID: 21979052 Free PMC article.

7

Antisense-mediated exon inclusion.

Hua Y, Krainer AR. Hua Y, et al. Methods Mol Biol. 2012;867:307-23. doi: 10.1007/978-1-61779-767-5_20. Methods Mol Biol. 2012. PMID: 22454070 Free PMC article.

8

Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives.

Kim YJ, Krainer AR. Kim YJ, et al. Mol Cells. 2023 Jan 31;46(1):10-20. doi: 10.14348/molcells.2023.2172. Epub 2023 Jan 15. Mol Cells. 2023. PMID: 36697233 Free PMC article. Review.

9

Higher-order epistasis and phenotypic prediction.

Zhou J, Wong MS, Chen WC, Krainer AR, Kinney JB, McCandlish DM. Zhou J, et al. Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2204233119. doi: 10.1073/pnas.2204233119. Epub 2022 Sep 21. Proc Natl Acad Sci U S A. 2022. PMID: 36129941 Free PMC article.

10

A generalizable pre-clinical research approach for orphan disease therapy.

Beaulieu CL, Samuels ME, Ekins S, McMaster CR, Edwards AM, Krainer AR, Hicks GG, Frey BJ, Boycott KM, Mackenzie AE. Beaulieu CL, et al. Orphanet J Rare Dis. 2012 Jun 15;7:39. doi: 10.1186/1750-1172-7-39. Orphanet J Rare Dis. 2012. PMID: 22704758 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

78 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year